Rep. Israel Mulls FDA Authority, Funding As Counterfeits Come To Forefront
This article was originally published in The Tan Sheet
Executive Summary
A bill introduced by Rep. Steve Israel (D-NY) would provide for an additional $300 mil. in funding to FDA over the next five years for inspections and investigations by the agency of incidents of drug counterfeiting